A new low-dose monophasic combination oral contraceptive (Alesse(TM)) with levonorgestrel 100 μg and ethinyl estradiol 20 μg

Contraception

Volumn 55, Issue 3, 1997, Pages 139-144

  Archer, David F ^a   Maheux, Rodolphe ^b   DelConte, Anthony ^c   O'Brien, Francis B ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c WYETH AYERST RESEARCH   (United States)

Author keywords

Alesse; breakthrough bleeding; ethinyl estradiol; levonorgestrel; oral contraceptive

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; LOW DOSE ORAL CONTRACEPTIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; METRORRHAGIA; MULTICENTER STUDY; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PREGNANCY RATE; SPOTTING;

ADOLESCENT; ADULT; AMENORRHEA; BLOOD PRESSURE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; HEADACHE; HUMANS; INCIDENCE; LEVONORGESTREL; LIFE TABLES; MENSTRUATION; METRORRHAGIA; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DROPOUTS; PREGNANCY; PREGNANCY RATE; SAFETY; UTERINE CERVICAL NEOPLASMS; UTERINE HEMORRHAGE;

EID: 0030888227     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00024-3     Document Type: Article

References (7)

1. Sartoretto JN, Ortega-Recio JC. Clinical evaluation of a low dosage estrogen-progesterone association (100 μg of d-norgestrel and 20 μg of ethinyl estradiol). Rev Bras Clin Terap 1974;3:399-404.
2. Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age. Contraception 1994;49:33-46.
3. Tietze C, Lewit S. Statistical evaluation of contraceptive methods. Clin Obstet & Gynecology 1974;17:121-38.
4. Bertelsen B, Hartviet F. The cervical smear record: its relevance to the subsequent development of cervical dysplasia. Acta Obstetrica et Gynelogica Scandinavia 1995;74:729-33.
5. Bounds W, Vessey M, Wiggins P. A randomized doubleblind trial of two low-dose combined oral contraceptives. Br J Obst Gynaecol 1979;86:325-9.
6. WHO Task Force on Oral Contraceptives. A randomized, double-blind study of six combined oral contraceptives. Contraception 1982;25:231-41.
7. WHO Task Force on Oral Contraceptives. A randomized, double-blind study of two combined and two progestogen-only oral contraceptives. Contraception 1982;25:243-52.